Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients

Journal of Neuroimmunology

Volumn 277, Issue 1-2, 2014, Pages 140-144

  Varzari, Alexander ^a,b   Bruch, Kathrin ^b   Deyneko, Igor V ^c   Chan, Andrew ^d   Epplen, Joerg T ^b,e   Hoffjan, Sabine ^b  

^a Microbiology and Morphology Laboratory   (Moldova)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d ST JOSEF HOSPITAL   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Association; Combinatorial effect; Multiple sclerosis; RIG I like receptors; RLRs

Indexed keywords

RETINOIC ACID INDUCIBLE PROTEIN I; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; DHX58 PROTEIN, HUMAN; IFIH1 PROTEIN, HUMAN; RNA HELICASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VISA PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GERMAN (CITIZEN); HUMAN; IFIH1 GENE; LGP2 GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; MUTATIONAL ANALYSIS; ONSET AGE; RECEPTOR GENE; RIG 1 GENE; RIG I LIKE RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VISA GENE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GERMANY; MIDDLE AGED;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; DEAD-BOX RNA HELICASES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA HELICASES;

EID: 84919389203     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.09.015     Document Type: Article

References (36)

1. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 2007, 61:288-299.
2. Barrett J.C. Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb. Protoc. 2009, (10:pdb.ip71).
3. Bergamaschi L., Ban M., Leone M.A., Sawcer S.J., D'Alfonso S. No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis. J. Neuroimmunol. 2010, 221:112-114.
4. Cen H., Wang W., Leng R.X., Wang T.Y., Pan H.F., Fan Y.G., Wang B., Ye D.Q. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 2013, 46:455-462.
5. Chistiakov D.A., Voronova N.V., Savost'Anov K.V., Turakulov R.I. Loss-of-function mutations E6 27X and I923V of IFIH1 are associated with lower poly(I:C)-induced interferon-beta production in peripheral blood mononuclear cells of type 1 diabetes patients. Hum. Immunol. 2010, 71:1128-1134.
6. Couturier N., Gourraud P.A., Cournu-Rebeix I., Gout C., Bucciarelli F., Edan G., Babron M.C., Clerget-Darpoux F., Clanet M., Fontaine B., Brassat D. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur. J. Hum. Genet. 2009, 17:844-847.
7. Cunninghame Graham D.S., Morris D.L., Bhangale T.R., Criswell L.A., Syvanen A.C., Ronnblom L., Behrens T.W., Graham R.R., Vyse T.J. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 2011, 7:e1002341.
8. Dann A., Poeck H., Croxford A.L., Gaupp S., Kierdorf K., Knust M., Pfeifer D., Maihoefer C., Endres S., Kalinke U., Meuth S.G., Wiendl H., Knobeloch K.P., Akira S., Waisman A., Hartmann G., Prinz M. Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat. Neurosci. 2011, 15:98-106.
9. Enevold C., Oturai A.B., Sorensen P.S., Ryder L.P., Koch-Henriksen N., Bendtzen K. Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1. J. Neuroimmunol. 2009, 212:125-131.
10. Ferreira R.C., Pan-Hammarstrom Q., Graham R.R., Gateva V., Fontan G., Lee A.T., Ortmann W., Urcelay E., Fernandez-Arquero M., Nunez C., Jorgensen G., Ludviksson B.R., Koskinen S., Haimila K., Clark H.F., Klareskog L., Gregersen P.K., Behrens T.W., Hammarstrom L. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat. Genet. 2010, 42:777-780.
11. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., Ortmann W., Kosoy R., Ferreira R.C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jonsen A., Bengtsson A.A., Rantapaa-Dahlqvist S., Baechler E.C., Brown E.E., Alarcon G.S., Edberg J.C., Ramsey-Goldman R., McGwin G., Reveille J.D., Vila L.M., Kimberly R.P., Manzi S., Petri M.A., Lee A., Gregersen P.K., Seldin M.F., Ronnblom L., Criswell L.A., Syvanen A.C., Behrens T.W., Graham R.R. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 2009, 41:1228-1233.
12. Hoffjan S., Akkad D.A. The genetics of multiple sclerosis: an update 2010. Mol. Cell. Probes 2010, 24:237-243.
13. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
14. Hundeshagen A., Hecker M., Paap B.K., Angerstein C., Kandulski O., Fatum C., Hartmann C., Koczan D., Thiesen H.J., Zettl U.K. Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance. J. Neuroinflammation 2012, 9:140.
15. Koch M.W., Metz L.M., Agrawal S.M., Yong V.W. Environmental factors and their regulation of immunity in multiple sclerosis. J. Neurol. Sci. 2013, 324:10-16.
16. Koch M.W., Metz L.M., Kovalchuk O. Epigenetic changes in patients with multiple sclerosis. Nat. Rev. Neurol. 2013, 9:35-43.
17. Lettre G., Lange C., Hirschhorn J.N. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 2007, 31:358-362.
18. Lewis C.M. Genetic association studies: design, analysis and interpretation. Brief. Bioinform. 2002, 3:146-153.
19. Lin R., Charlesworth J., van der Mei I., Taylor B.V. The genetics of multiple sclerosis. Pract. Neurol. 2012, 12:279-288.
20. Liu S., Wang H., Jin Y., Podolsky R., Reddy M.V., Pedersen J., Bode B., Reed J., Steed D., Anderson S., Yang P., Muir A., Steed L., Hopkins D., Huang Y., Purohit S., Wang C.Y., Steck A.K., Montemari A., Eisenbarth G., Rewers M., She J.X. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet. 2009, 18:358-365.
21. Liu X., Jiao Y., Wen X., Wang L., Ma C., Gao X., Chen Z.J., Zhao Y. Possible association of VISA gene polymorphisms with susceptibility to systemic lupus erythematosus in Chinese population. Mol. Biol. Rep. 2011, 38:4583-4588.
22. Liu S.M., Xu F.X., Shen F., Xie Y. Rapid genotyping of APOA5-1131T>C polymorphism using high resolution melting analysis with unlabeled probes. Gene 2012, 498:276-279.
23. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
24. Martinez A., Santiago J.L., Cenit M.C., de Las Heras V., de la Calle H., Fernandez-Arquero M., Arroyo R., de la Concha E.G., Urcelay E. IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk. Eur. J. Hum. Genet. 2008, 16:861-864.
25. Molineros J.E., Maiti A.K., Sun C., Looger L.L., Han S., Kim-Howard X., Glenn S., Adler A., Kelly J.A., Niewold T.B., Gilkeson G.S., Brown E.E., Alarcon G.S., Edberg J.C., Petri M., Ramsey-Goldman R., Reveille J.D., Vila L.M., Freedman B.I., Tsao B.P., Criswell L.A., Jacob C.O., Moore J.H., Vyse T.J., Langefeld C.L., Guthridge J.M., Gaffney P.M., Moser K.L., Scofield R.H., Alarcon-Riquelme M.E., Williams S.M., Merrill J.T., James J.A., Kaufman K.M., Kimberly R.P., Harley J.B., Nath S.K. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet. 2013, 9:e1003222.
26. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
27. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
28. Pothlichet J., Niewold T.B., Vitour D., Solhonne B., Crow M.K., Si-Tahar M. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol. Med. 2011, 3:142-152.
29. Qu H.Q., Marchand L., Grabs R., Polychronakos C. The association between the IFIH1 locus and type 1 diabetes. Diabetologia 2008, 51:473-475.
30. Rose A.M., Bell L.C. Epistasis and immunity: the role of genetic interactions in autoimmune diseases. Immunology 2012, 137:131-138.
31. Sawcer S., Franklin R.J., Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014, 13:700-709.
32. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007, 204:2899-2912.
33. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., Guja C., Ionescu-Tirgoviste C., Widmer B., Dunger D.B., Savage D.A., Walker N.M., Clayton D.G., Todd J.A. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 2006, 38:617-619.
34. Soldan S.S., Jacobson S. Role of viruses in etiology and pathogenesis of multiple sclerosis. Adv. Virus Res. 2001, 56:517-555.
35. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
36. Suresh R., Mosser D.M. Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv. Physiol. Educ. 2013, 37:284-291.